NCT01621620

The Role of Sympatho-vagal Balance on Different Limbs of Pain Perception in Healthy Subjects

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Tel-Aviv Sourasky Medical Center · Other Government
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

objectives 1. To study the sympatho-vagal balance effect on different limbs of pain perception. 2. To determine whether it is the hypertension by itself or the baroreflex activation due to blood pressure rise that is responsible for the analgesic effect of acute hypertension. study questions The study questions are derived from the study objectives: 1. Does sympatho-vagal balance influence pain perception? 2. Does sympatho-vagal balance influence diffuse noxious inhibitory control systems? 3. Does sympatho-vagal balance influence temporal summation? 4. Does the hypoalgesic effect to acute increase in blood pressure a result of baroreflex activation?

Detailed description

Hypothesis We hypothesize that the activation of the sympathetic system, which leads to increased hypertension, rather than the cholinergic response to increased BP, is responsible for antinociceptive effect of hypertension. 2.b objectives 1. To study the sympatho-vagal balance effect on different limbs of pain perception. 2. To determine whether it is the hypertension by itself or the baroreflex activation due to blood pressure rise that is responsible for the analgesic effect of acute hypertension. 2.c study questions The study questions are derived from the study objectives: 1. Does sympatho-vagal balance influence pain perception? 2. Does sympatho-vagal balance influence diffuse noxious inhibitory control systems? 3. Does sympatho-vagal balance influence temporal summation? 4. Does the hypoalgesic effect to acute increase in blood pressure a result of baroreflex activation? 3\. Subjects and methods 3.a subjects Every subject will be invited to 2 separate sessions. At least 24 hours will apart the two sessions. The test in each session is described in details in the Hebrew protocol attached to the current protocol in English. An informed consent will be signed by each subject prior to a thorough interview. The interview, composed of several question regarding prior health problems, current or past use of medications as well as demographic details (as detailed in the Hebrew protocol) will take place in the test room prior to the beginning of the first session. Screening tests will include detailed interview, blood pressure, heart rate and ECG strip at the beginning of the first(but not the second) session. The first measurement will be taken following 15 minutes complete rest. The second and the third after 5 and 10 minutes, respectively. Blood examinations are not required in this study. Healthy subjects: 20 age matched subjects (20-50).

Conditions

• Pain

Interventions

Type	Name	Description
DRUG	Yohimbine

Timeline

• Start date: 2012-08-01
• Primary completion: 2013-08-01
• Completion: 2014-08-01
• First posted: 2012-06-18
• Last updated: 2012-06-18

Locations

1 site across 1 country: Israel